Antioxidant treatment does not prevent chronic hypoxia-induced respiratory muscle impairment in developing rats

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Litters of rats were exposed to normobaric normoxia or hypobaric hypoxia (PB = 450 mmHg) for 7 days at 3 different time points during early development (postnatal day (P)1, P6 & P11). A separate litter exposed to hypoxia at P11 was treated with the antioxidant Tempol (100 mg/kg) given by oral administration daily starting at P8. At P19, sternohyoid and diaphragm muscles were removed and isolated muscle bundles were mounted isometrically in physiological salt solution at 30°C in vitro. Fatigue was assessed in response to repeated stimulation (40 Hz) every 2 s for 5 min. Fatigue index was measured. Chronic hypoxia decreased sternohyoid, but not diaphragm, muscle endurance. Tempol treatment did not prevent hypoxia-induced muscle plasticity, suggesting that reactive oxygen species are not implicated in hypoxia-induced muscle dysfunction. © Springer Science+Business Media, LLC 2010.

Cite

CITATION STYLE

APA

Carberry, J., Bradford, A., & O’Halloran, K. D. (2010). Antioxidant treatment does not prevent chronic hypoxia-induced respiratory muscle impairment in developing rats. In Advances in Experimental Medicine and Biology (Vol. 669, pp. 263–266). https://doi.org/10.1007/978-1-4419-5692-7_53

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free